Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Radiation Enhancement by The Combined Use of CPT-11 and Etoposide in Human Lung Cancer Cells

Kim JS, Kim JS, Cho MJ

  • KMID: 2200235
  • J Lung Cancer.
  • 2002 Dec;1(1):60-65.
PURPOSE: To evaluate the radiation enhancement by a combination of CPT-11 and etoposide, with in vitro ionizing radiation. MATERIALS AND METHODS: H460 human lung carcinoma cells were plated, and treated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
K-ras Gene Mutation in Non-Small Cell Lung Cancer

Yoon HJ, Ju JY, Cho GJ, Kim EJ, Park KH, Kim KS, Ko YC, Lim SC, Kim YC, Park KO, Park JT

  • KMID: 2200234
  • J Lung Cancer.
  • 2002 Dec;1(1):55-59.
PURPOSE: Point mutation of the K-ras gene causes irreversible binding of GTP to the P21-ras protein, which induces nuclear transcription factors and enhances cellular proliferation. Point mutation of the K-ras...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fractionated Stereotactic Radiotherapy for Metastatic Brain Tumor in Non-Small Cell Lung Cancer

Cho MJ, Kim KH, Kim JS, Kim SH, Song SH, Song CJ, Lim SP, Kim SY, Kim JS

  • KMID: 2200232
  • J Lung Cancer.
  • 2002 Dec;1(1):48-54.
PURPOSE: To evaluate the results of treatment with fractionated stereotactic radiotherapy for metastatic brain tumors in non-small cell lung cancer. MATERIALS AND METHODS: Between August 1997 and August 2001, 17...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary Results of Stereotactic Body Frame Based Fractionated Radiosurgery on Consecutive Days for Primary Lung Cancer or Metastatic Lung Tumors

Lee SW, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, Yoon SM, Kim YS, Yi BY

  • KMID: 2200231
  • J Lung Cancer.
  • 2002 Dec;1(1):41-47.
To evaluate the feasibility and treatment outcomes of stereotactic radiosurgery (SRS) using a stereotactic body frame (Precision TherapyTM), we prospectively reviewed 34 tumors of the 28 patients with primary or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Postoperative Adjuvant Chemotherapy and Radiotherapy for Stage II and III Non-Small Cell Lung Cancer (NSCLC)

Park JH, Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH

  • KMID: 2200230
  • J Lung Cancer.
  • 2002 Dec;1(1):34-40.
PURPOSE: The role of postoperative adjuvant chemo-radiotherapy in the treatment of patients with non-small cell lung cancer (NSCLC) remains unclear. This study was undertaken to evaluate the survival outcomes, relapse...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemo-radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

Oh YT, Chun M, Choi JH, Lim HY, Kang S

  • KMID: 2200228
  • J Lung Cancer.
  • 2002 Dec;1(1):29-33.
PURPOSE: Chemotherapy, followed by radiation therapy, improves the survival of patients with locally advanced non-small cell lung cancer (NSCLC). However, it is not clear whether chemotherapy, followed by concurrent chemo-radiation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
DNA Methylation in Lung Cancer

Lee MK

  • KMID: 2200226
  • J Lung Cancer.
  • 2002 Dec;1(1):23-28.
DNA modification in vertebrate genomes is confined to the self-complementary sequence CpG. Between 60% and 90% of CpGs are methylated at the 5 position of cytosine, and the remainder is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiotherapy for Locally Advanced Lung Cancer

Park CI, Choi EK

  • KMID: 2200224
  • J Lung Cancer.
  • 2002 Dec;1(1):15-22.
Lung cancer is the leading cause of cancer deaths. Non-small cell lung cancer constitutes approximately 75% of lung cancers, and 40% will present as advanced stage IIIa or IIIb, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgery for Locally Advanced Non-Small Cell Lung Cancer

Kim YT

  • KMID: 2200223
  • J Lung Cancer.
  • 2002 Dec;1(1):9-14.
Surgical resection of locally advanced lung cancer is a challenging subject for thoracic surgeons. Although the operative mortality and morbidity have recently decreased, extended pulmonary resection still remains a high-risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Trend in The Treatment of Non-Small Cell Lung Cancer Non-small cell lung cancer

Lee KY

  • KMID: 2200222
  • J Lung Cancer.
  • 2002 Dec;1(1):1-8.
(NSCLC) accounts for more than 80% of all lung cancer cases. Even though surgery plays a key role in the curative management of NSCLC, especially the stage I or II...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr